Malignancy and systemic lupus erythematosus.

被引：36

作者：

Bernatsky S. ^{[1
]}

Clarke A. ^{[1
]}

Ramsey-Goldman R. ^{[1
]}

机构：

[1] Northwestern University, Division of Rheumatology, Arthritis, 303 East Chicago Avenue, Chicago, 60611-3088, IL

来源：

Current Rheumatology Reports | 2002年 / 4卷 / 4期

基金：

加拿大健康研究院; 美国国家卫生研究院;

关键词：

Systemic Lupus Erythematosus; Chronic Lymphocytic Leukemia; Lupus Nephritis; Cervical Dysplasia; Malignancy Risk;

D O I：

10.1007/s11926-002-0045-6

中图分类号：

学科分类号：

摘要：

The association of malignancy with systemic lupus erythematosus (SLE) has been investigated for years. The findings of cohort studies lend support for an increased risk of malignancy in SLE but are difficult to interpret definitively. In addition, several cohort studies have suggested an increased risk of non-Hodgkin's lymphoma but with imprecise estimation. There is inadequate evidence for any conclusions about the risk of solid tumors in these patients. A multicenter international research effort is in progress to elucidate these issues and to establish the role of exposures such as cytotoxic or immunomodulatory therapy. The recommendations advocated for cancer screening policies and for minimizing known risk factors for cancer in the general population should not be neglected in persons with SLE.

引用

页码：351 / 358

页数：7

共 187 条

[1] Stahl-Hallengren C(2000)Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis J Rheumatol 27 685-691
[2] Jonsen A(1992)Risk of cancer in patients with dermatomyositis or polymyositis: a population based study N Engl J Med 326 363-367
[3] Nived O(1990)Nodal and extranodal lymphoproliferative disorders in Sjogren’s syndrome: a clinical and immunopathological study Hum Pathol 21 482-492
[4] Sturfelt G(1985)Cancer and systemic sclerosis, an epidemiological study Arthritis Rheum 28 1336-1340
[5] Sigureirsson B(2000)Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five different rheumatic diseases in one institution J Clin Rheumatol 6 176-183
[6] Lindelof B(1991)MHC complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mouse: a model for B cell chronic lymphocytic leukemia and autoimmune disease Eur J Immunol 21 2743-2748
[7] Edhag O(1994)Lupus susceptibility loci in New Zealand mouse Proc Natl Acad Sci U S A 91 10168-10172
[8] Allander E(1998)Susceptibility alleles for aberrant B-1 cell proliferation involved in spontaneously occurring B-cell chronic lymphocytic leukemia in a model of New Zealand White mice Blood 92 3772-3779
[9] McCurley TE(2000)Linkage analysis for major histocompatibility complex-related genetic susceptibility in familial chronic lymphocytic leukemia Blood 96 3982-3984
[10] Collins RD(2000)Systemic lupus erythematosus, complement deficiency, and apoptosis Adv Immunol 76 227-324

← 1 2 3 4 5 6 7 8 9 10 →